PriceTargets.com logo

Healthpeak Properties - PEAK Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $19.70
  • Forecasted Upside: ∞
  • Number of Analysts: 5
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.00 As of 03/2/2024 12:59 AM ET
+0 (0.00%)
Get New Healthpeak Properties Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PEAK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PEAK

Analyst Price Target is $19.70
▲ +∞ Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Healthpeak Properties in the last 3 months. The average price target is $19.70, with a high forecast of $22.00 and a low forecast of $17.50. The average price target represents a ∞ upside from the last price of $0.00.

This chart shows the closing price for PEAK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 5 contributing investment analysts is to hold stock in Healthpeak Properties. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
5/9/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/4/2024ScotiabankLower TargetSector Outperform ➝ Sector Outperform$23.00 ➝ $22.00
2/12/2024BNP ParibasUpgradeUnderperform ➝ Neutral$19.00
1/30/2024Deutsche Bank AktiengesellschaftInitiated CoverageHold$21.00
1/12/2024ScotiabankUpgradeSector Perform ➝ Sector Outperform$20.00 ➝ $23.00
11/13/2023Bank of AmericaDowngradeNeutral ➝ Underperform$17.50
10/31/2023WedbushReiterated RatingNeutral ➝ Neutral$19.00
10/11/2023BNP ParibasInitiated CoverageUnderperform$18.00
10/5/2023ScotiabankLower TargetSector Perform ➝ Sector Perform$22.00 ➝ $20.00
10/3/2023WedbushInitiated CoverageNeutral$19.00
9/7/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$25.00 ➝ $22.00
7/25/2023BarclaysLower TargetOverweight$33.00 ➝ $32.00
4/28/2023Stifel NicolausLower Target$34.00 ➝ $30.00
4/24/2023MizuhoUpgradeNeutral ➝ Buy$29.00 ➝ $25.00
4/19/2023Wells Fargo & CompanyInitiated CoverageEqual Weight$23.00
4/5/2023CitigroupDowngradeBuy ➝ Neutral$23.00
3/31/2023ScotiabankDowngradeSector Outperform ➝ Sector Perform$24.00
3/10/2023Morgan StanleyBoost TargetEqual Weight$23.00 ➝ $25.00
2/28/2023CitigroupLower TargetBuy$30.00 ➝ $27.50
2/10/2023BarclaysLower TargetOverweight$34.00 ➝ $33.00
1/2/2023Jefferies Financial GroupUpgradeHold ➝ Buy$23.00 ➝ $29.00
12/14/2022Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$35.00 ➝ $28.00
11/21/2022Evercore ISIUpgradeIn-Line ➝ Outperform$28.00
11/1/2022Morgan StanleyLower TargetEqual Weight$27.00 ➝ $23.00
9/28/2022Wolfe ResearchUpgradePeer Perform ➝ Outperform$27.00
9/9/2022BarclaysLower TargetOverweight$38.00 ➝ $36.00
8/31/2022Morgan StanleyBoost TargetEqual Weight$26.00 ➝ $27.00
7/29/2022MizuhoLower TargetNeutral$37.00 ➝ $29.00
7/15/2022Morgan StanleyLower TargetEqual Weight$32.50 ➝ $26.00
7/8/2022CitigroupUpgradeNeutral ➝ Buy$33.00 ➝ $31.00
6/30/2022Jefferies Financial GroupLower TargetHold$33.00 ➝ $26.00
6/20/2022Evercore ISISet Target$32.00
6/3/2022Capital One FinancialInitiated CoverageEqual Weight ➝ Equal Weight$34.00
6/1/2022Morgan StanleyLower TargetEqual Weight$34.50 ➝ $32.50
5/19/2022Bank of AmericaDowngradeBuy ➝ Neutral$32.00
4/4/2022Credit Suisse GroupBoost TargetNeutral$37.00 ➝ $38.00
3/7/2022Morgan StanleyLower TargetEqual Weight$35.50 ➝ $34.50
2/1/2022Credit Suisse GroupInitiated CoverageNeutral
12/20/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$38.00 ➝ $40.00
12/6/2021Wolfe ResearchInitiated CoverageMarket Perform$36.00
11/29/2021Morgan StanleyLower TargetEqual Weight$37.00 ➝ $35.50
11/18/2021Royal Bank of CanadaBoost TargetOutperform$39.00 ➝ $40.00
9/13/2021Morgan StanleyBoost TargetEqual Weight$32.00 ➝ $37.00
8/17/2021Royal Bank of CanadaBoost TargetOutperform$36.00 ➝ $39.00
7/26/2021Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $32.00
7/23/2021Wells Fargo & CompanyBoost TargetUnderweight$32.00 ➝ $36.00
7/14/2021MizuhoReiterated RatingNeutral$32.00
6/15/2021ArgusBoost TargetBuy$34.00 ➝ $39.00
5/26/2021JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$33.00 ➝ $34.00
5/24/2021Royal Bank of CanadaBoost TargetOutperform$35.00 ➝ $36.00
5/20/2021Berenberg BankUpgradeHold ➝ Buy
5/20/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$33.00 ➝ $34.00
5/6/2021BarclaysBoost TargetOverweight$33.00 ➝ $36.00
4/14/2021Wells Fargo & CompanyBoost Target$25.00 ➝ $32.00
3/30/2021Bank of AmericaUpgradeNeutral ➝ Buy$34.00 ➝ $35.50
3/15/2021Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $30.00
2/9/2021MizuhoBoost TargetNeutral$29.00 ➝ $32.00
1/20/2021Capital One FinancialUpgradeEqual Weight ➝ Overweight
12/29/2020BarclaysBoost TargetOverweight$30.00 ➝ $33.00
12/15/2020Smith Barney CitigroupBoost Target$28.00 ➝ $30.00
12/14/2020KeyCorpDowngradeOverweight ➝ Sector Weight
12/10/2020Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$26.00 ➝ $25.00
11/4/2020Raymond JamesReiterated RatingBuy
10/16/2020MizuhoDowngradeBuy ➝ Neutral$30.00 ➝ $29.00
9/4/2020BarclaysBoost TargetOverweight$28.00 ➝ $30.00
9/1/2020Stifel NicolausInitiated CoverageBuy$31.00
8/21/2020Morgan StanleyBoost TargetEqual Weight$28.00 ➝ $29.00
7/2/2020CitigroupBoost TargetNeutral$24.00 ➝ $28.00
7/2/2020Berenberg BankInitiated CoverageHold
5/22/2020BMO Capital MarketsReiterated RatingBuy$30.00
5/14/2020Royal Bank of CanadaLower Target$32.00 ➝ $27.00
4/29/2020Raymond JamesDowngradeOutperform ➝ Market Perform
4/21/2020MizuhoLower TargetBuy$41.00 ➝ $30.00
4/21/2020KeyCorpLower TargetOverweight$37.00 ➝ $30.00
4/14/2020Royal Bank of CanadaReiterated RatingBuy$32.00
4/8/2020BarclaysReiterated RatingBuy$28.00
4/7/2020CitigroupLower TargetNeutral$38.00 ➝ $24.00
4/3/2020JPMorgan Chase & Co.Lower TargetOverweight$38.00 ➝ $29.00
3/27/2020Wells Fargo & CompanyLower TargetEqual Weight$35.00 ➝ $26.00
3/25/2020Raymond JamesLower TargetOutperform$37.00 ➝ $28.00
3/23/2020Bank of AmericaDowngradeBuy ➝ Neutral
3/17/2020Morgan StanleyLower TargetEqual Weight$35.00 ➝ $28.00
3/9/2020Royal Bank of CanadaReiterated RatingBuy$40.00
2/13/2020BMO Capital MarketsReiterated RatingBuy$38.00
2/12/2020MizuhoReiterated RatingBuy$38.00
12/19/2019MizuhoInitiated CoverageBuy$39.00
(Data available from 10/30/2019 forward)

News Sentiment Rating

0.21 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2024
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2024
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 1 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024

Current Sentiment

  • 1 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Healthpeak Properties logo
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $17.72
Low: $16.18
High: $20.73

52 Week Range

Now: N/A

Volume

9,979,100 shs

Average Volume

7,814,412 shs

Market Capitalization

$9.36 billion

P/E Ratio

30.54

Dividend Yield

7.02%

Beta

1.01

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthpeak Properties?

The following equities research analysts have issued stock ratings on Healthpeak Properties in the last twelve months: Bank of America Co., BNP Paribas, Deutsche Bank Aktiengesellschaft, Scotiabank, and Wedbush.
View the latest analyst ratings for PEAK.

What is the current price target for Healthpeak Properties?

5 Wall Street analysts have set twelve-month price targets for Healthpeak Properties in the last year. Their average twelve-month price target is $19.70. Scotiabank has the highest price target set, predicting PEAK will reach $22.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $17.50 for Healthpeak Properties in the next year.
View the latest price targets for PEAK.

What is the current consensus analyst rating for Healthpeak Properties?

Healthpeak Properties currently has 1 sell rating, 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in PEAK, but not buy more shares or sell existing shares.
View the latest ratings for PEAK.

What other companies compete with Healthpeak Properties?

Other companies that are similar to Healthpeak Properties include Iron Mountain, Extra Space Storage, VICI Properties, AvalonBay Communities and Equity Residential. Learn More about companies similar to Healthpeak Properties.

How do I contact Healthpeak Properties' investor relations team?

Healthpeak Properties' physical mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The company's listed phone number is (720) 428-5050 and its investor relations email address is [email protected]. The official website for Healthpeak Properties is www.healthpeak.com. Learn More about contacing Healthpeak Properties investor relations.